Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: Results of a phase 2 randomized study

Cited in:

CrossRef

This article has been cited by:

1. 1
   Philip Meuleman, Maria Teresa Catanese, Lieven Verhoye, Isabelle Desombere, Ali Farhoudi, Christopher T. Jones, Timothy Sheahan, Katarzyna Grzyb, Riccardo Cortese, Charles M. Rice, Geert Leroux-Roels, Alfredo Nicosia, A Human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo, Hepatology, 2012, 55, 2

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(435K)
   • References
2. 2
   Bruno Roche, Didier Samuel, Hepatitis C virus treatment pre- and post-liver transplantation, Liver International, 2012, 32,

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(188K)
   • References
3. 3
   Marie A. Laryea, Kymberly D. Watt, Immunoprophylaxis against and prevention of recurrent viral hepatitis after liver transplantation, Liver Transplantation, 2012, 18, 5

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(774K)
   • References
4. 4
   Krzysztof Lacek, Koen Vercauteren, Katarzyna Grzyb, Mariarosaria Naddeo, Lieven Verhoye, Marek Patryk SÅ‚owikowski, Samira Fafi-Kremer, Arvind H. Patel, Thomas F. Baumert, Antonella Folgori, Geert Leroux-Roels, Riccardo Cortese, Philip Meuleman, Alfredo Nicosia, Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice, Journal of Hepatology, 2012,

   CrossRef

5. 5
   Jennifer C. Lai, Norah A. Terrault, Zakim and Boyer's Hepatology, 2012,

   CrossRef

6. 6
   J. Dragun, S. Pérez-del-Pulgar, G. Crespo, S. Ramírez, M. Coto-Llerena, L. Mensa, J. C. García-Valdecasas, M. Navasa, X. Forns, Characterization of the Cross-Neutralizing Antibody Response Against Hepatitis C Virus in the Liver Transplantation Setting, American Journal of Transplantation, 2011, 11, 4

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(240K)
   • References
7. 7
   Joseph Ahn, Steven L. Flamm, Hepatitis C Therapy: Other Players in the Game, Clinics in Liver Disease, 2011, 15, 3, 641

   CrossRef

8. 8
   Mirjam B. Zeisel, Isabel Fofana, Samira Fafi-Kremer, Thomas F. Baumert, Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies, Journal of Hepatology, 2011, 54, 3, 566

   CrossRef

9. 9
   Allan GN Angus, Arvind H Patel, Immunotherapeutic potential of neutralizing antibodies targeting conserved regions of the HCV envelope glycoprotein E2, Future Microbiology, 2011, 6, 3, 279

   CrossRef

10. 10
    Reddy K Rajender, Chalermrat Bunchorntavakul, Managing hepatitis C: Before and after liver transplantation, Indian Journal of Transplantation, 2011, 5, 2, 72

    CrossRef

11. 11
    Ingmar Mederacke, Thomas von Hahn, Survival of the fittest: Selection of hepatitis C virus variants during liver graft reinfection , Hepatology, 2011, 53, 2

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(238K)
    • References
12. 12
    V. C. Edwards, A. W. Tarr, R. A. Urbanowicz, J. K. Ball, The role of neutralizing antibodies in hepatitis C virus infection, Journal of General Virology, 2011, 93, 1, 1

    CrossRef

13. 13
    Weijia Cai, Liya Su, Qingjiao Liao, Linbai Ye, Yang Wu, Zhenghui Wu, Yinglong She, Expression, purification and immunogenic characterization of hepatitis C virus recombinant E1E2 protein expressed by Pichia pastoris yeast, Antiviral Research, 2010, 88, 1, 80

    CrossRef

14. 14
    Nyingi M. Kemmer, Tiffany E. Kaiser, Guy W. Neff, Hepatitis C After Liver Transplantation: Treatment and Impact on Patient and Graft Survival, Current Hepatitis Reports, 2010, 9, 3, 161

    CrossRef

15. 15
    S. Fafi-Kremer, I. Fofana, E. Soulier, P. Carolla, P. Meuleman, G. Leroux-Roels, A. H. Patel, F.-L. Cosset, P. Pessaux, M. Doffoel, P. Wolf, F. Stoll-Keller, T. F. Baumert, Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation, Journal of Experimental Medicine, 2010, 207, 9, 2019

    CrossRef

16. 16
    Jacqueline G. O’Leary, Gary L. Davis, Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 2010,

    CrossRef

17. 17
    Takuya Matsumura, Zongyi Hu, Takanobu Kato, Marlene Dreux, Yong–Yuan Zhang, Michio Imamura, Nobuhiko Hiraga, Jean–Marc Juteau, Francois–Loic Cosset, Kazuaki Chayama, Andrew Vaillant, T. Jake Liang, Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral Entry, Gastroenterology, 2009, 137, 2, 673

    CrossRef

18. 18
    Jan Peveling-Oberhag, Stefan Zeuzem, Wolf Peter Hofmann, Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation, Medical Microbiology and Immunology, 2009, 199, 1, 1

    CrossRef

19. 19
    Kimberly A. Forde, K. Rajender Reddy, Hepatitis C Virus Infection and Immunomodulatory Therapies, Clinics in Liver Disease, 2009, 13, 3, 391

    CrossRef

20. 20
    Heshaam M. Mir, Aybike Birerdinc, Zobair M. Younossi, Monoclonal and Polyclonal Antibodies Against the HCV Envelope Proteins, Clinics in Liver Disease, 2009, 13, 3, 477

    CrossRef

21. You have free access to this content21
    J. De Bruijne, C. J. Weegink, P. L. M. Jansen, H. W. Reesink, New developments in the antiviral treatment of hepatitis C, Vox Sanguinis, 2009, 97, 1

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(276K)
    • References
22. 22
    Fredric D. Gordon, Paul Kwo, Hugo E. Vargas, Treatment of hepatitis C in liver transplant recipients, Liver Transplantation, 2009, 15, 2

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(182K)
    • References
23. 23
    Douglas Meyer, Kirti Shetty, Treatment of recurrent hepatitis C following liver transplantation, Current Hepatitis Reports, 2009, 6, 2, 54

    CrossRef

24. 24
    Elizabeth C. Verna, Robert S. Brown, Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted, Clinics in Liver Disease, 2008, 12, 3, 637

    CrossRef

25. 25
    Norah A. Terrault, Hepatitis C therapy before and after liver transplantation, Liver Transplantation, 2008, 14, S2

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(149K)
    • References
26. 26
    Thomas Vanwolleghem, Jens Bukh, Philip Meuleman, Isabelle Desombere, Jean-Christophe Meunier, Harvey Alter, Robert H. Purcell, Geert Leroux-Roels, Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver–chimeric mice from infection with a homologous hepatitis C virus strain, Hepatology, 2008, 47, 6

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(398K)
    • References
27. 27
    L. Margusino Framiñán, F. Suárez López, I. Martín Herranz, Profilaxis y tratamiento de la hepatopatía por virus C en el entorno del trasplante hepático. Revisión narrativa, Farmacia Hospitalaria, 2008, 32, 2, 102

    CrossRef

28. 28
    Luis Margusino Framiñán, Francisco Suárez López, Isabel Martín Herranz, The Profilaxis and Treatment of C Virus Liver Disease in the Liver Transplantation Setting. Narrative Review, Farmacia Hospitalaria (English Edition), 2008, 32, 2, 102

    CrossRef

29. 29
    Roberto J. Firpi, David R. Nelson, Current and Future Hepatitis C Therapies, Archives of Medical Research, 2007, 38, 6, 678

    CrossRef

30. 30
    Lawrence U Liu, Thomas D Schiano, Hepatitis C immune globulin (human) for the prevention of viral recurrence after liver transplantation, Expert Review of Clinical Immunology, 2007, 3, 2, 125

    CrossRef

31. 31
    P. Zhang, C. G. Wu, K. Mihalik, M. L. Virata-Theimer, M.-y. W. Yu, H. J. Alter, S. M. Feinstone, Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma, Proceedings of the National Academy of Sciences, 2007, 104, 20, 8449

    CrossRef

32. 32
    Jan ter Meulen, Monoclonal antibodies for prophylaxis and therapy of infectious diseases, Expert Opinion on Emerging Drugs, 2007, 12, 4, 525

    CrossRef

33. 33
    Jean–Michel Pawlotsky, Stéphane Chevaliez, John G. McHutchison, The Hepatitis C Virus Life Cycle as a Target for New Antiviral Therapies, Gastroenterology, 2007, 132, 5, 1979

    CrossRef

34. 34
    Gary L. Davis, Hepatitis C immune globulin to prevent HCV recurrence after liver transplantation: Chasing windmills?, Liver Transplantation, 2006, 12, 9

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(62K)
    • References
35. 35
    Carlos G Fasola, Goran B Klintmalm, Hepatitis C recurrence after liver transplantation: in search of the optimal immunosuppression to improve outcome, Current Opinion in Organ Transplantation, 2006, 11, 6, 637

    CrossRef

36. 36
    Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis, Brian R Davidson, Andrew K Burroughs, Antiviral prophylactic intervention for chronic hepatitis C virus in patients undergoing liver transplantation, The Cochrane Library,

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(611K)
    • References
37. 37
    Norah Terrault, Liver Transplantation in Patients with Hepatitis B, C or HIV Infection,

    Direct Link:

    • Summary
    • PDF(14563K)
    • References
38. 38
    Ed Gane, Prevention and Treatment of Recurrent HBV and HCV Infection,

    Direct Link:

    • Summary
    • PDF(89K)
    • References
39. 39
    Ed Gane, Treatment of Recurrent Hepatitis C Following Liver Transplantation,

    Direct Link:

    • Summary
    • PDF(144K)
    • References